共 50 条
- [41] Disease and treatment factors influencing outcomes in fistulising crohn's disease [J]. GUT, 2023, 72 (SUPPL_1) : A203 - A204
- [43] Biologic Therapy in Patients With Perianal Crohn's Disease and Association With Long-Term Rates of Surgical and Clinical Outcomes [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S354 - S354
- [45] Patient Characteristics and Clinical Outcomes in Biologic-Naive Patients With Crohn's Disease Initiating Vedolizumab Treatment Early Versus Later After Diagnosis [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 : S8 - S8
- [46] Obesity and Inflammatory Bowel Disease: Outcomes of Patients in a Pro-inflammatory State on Biologic Therapy for Crohn's Disease and Ulcerative Colitis [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 : S585 - S585
- [48] Dose Escalation of Biologic Therapies in Biologic Treatment-Naive Patients With Crohn's Disease: Results From the ODESSA-CD Study [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S570 - S571
- [50] Objectives and outcomes in the conventional treatment of pediatric Crohn's disease [J]. JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2001, 33 : S11 - S18